Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Miyazaki

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
International Journal of Hematology|May 27, 2020
Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective studyTaiki Ando, Shin Fujisawa, Haruka Teshigawara, et al.
International Journal of Hematology|January 22, 2010
Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditionsTakuya Miyazaki, Yohei Kirino, Mitsuhiro Takeno, et al.
Scientific Reports|September 11, 2021
Compromised anti-tumor-immune features of myeloid cell components in chronic myeloid leukemia patientsIbuki Harada, Haruka Sasaki, Koichi Murakami, et al.
Internal Medicine (Tokyo, Japan)|March 16, 2025
Delayed Methotrexate Elimination Following High-dose Methotrexate Prophylaxis in High-risk Diffuse Large B-cell LymphomaMasahiro Akimoto, Takuya Miyazaki, Hiroyuki Takahashi, et al.
International Journal of Hematology|May 12, 2026
Personalized multivariable clinical prognostic model for patients with acute myeloid leukemia receiving intensive chemotherapyKengo Katsuki, Takuya Miyazaki, Moka Komaki, et al.
Transplantation and Cellular Therapy|January 22, 2024
Pretransplantation Inflammatory and Nutritional Status in Elderly Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Value of C-Reactive Protein-to-Albumin RatioTakuya Miyazaki, Takayoshi Tachibana, Taisei Suzuki, et al.
Journal of Autoimmunity|March 23, 2017
DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in miceTomomi Sakai, Takuya Miyazaki, Dong-Mi Shin, et al.
Leukemia Research|December 27, 2014
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapyYuki Nakajima, Naoto Tomita, Megumi Itabashi, et al.
International Journal of Hematology|April 10, 2019
Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemiaTaiki Ando, Shin Fujisawa, Haruka Teshigawara, et al.
International Journal of Hematology|January 17, 2024
Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapseMasahiro Akimoto, Takuya Miyazaki, Hiroyuki Takahashi, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
International Journal of Hematology|May 27, 2020
Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective studyTaiki Ando, Shin Fujisawa, Haruka Teshigawara, et al.
International Journal of Hematology|January 22, 2010
Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditionsTakuya Miyazaki, Yohei Kirino, Mitsuhiro Takeno, et al.
Scientific Reports|September 11, 2021
Compromised anti-tumor-immune features of myeloid cell components in chronic myeloid leukemia patientsIbuki Harada, Haruka Sasaki, Koichi Murakami, et al.
Internal Medicine (Tokyo, Japan)|March 16, 2025
Delayed Methotrexate Elimination Following High-dose Methotrexate Prophylaxis in High-risk Diffuse Large B-cell LymphomaMasahiro Akimoto, Takuya Miyazaki, Hiroyuki Takahashi, et al.
International Journal of Hematology|May 12, 2026
Personalized multivariable clinical prognostic model for patients with acute myeloid leukemia receiving intensive chemotherapyKengo Katsuki, Takuya Miyazaki, Moka Komaki, et al.
Transplantation and Cellular Therapy|January 22, 2024
Pretransplantation Inflammatory and Nutritional Status in Elderly Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Value of C-Reactive Protein-to-Albumin RatioTakuya Miyazaki, Takayoshi Tachibana, Taisei Suzuki, et al.
Journal of Autoimmunity|March 23, 2017
DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in miceTomomi Sakai, Takuya Miyazaki, Dong-Mi Shin, et al.
Leukemia Research|December 27, 2014
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapyYuki Nakajima, Naoto Tomita, Megumi Itabashi, et al.
International Journal of Hematology|April 10, 2019
Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemiaTaiki Ando, Shin Fujisawa, Haruka Teshigawara, et al.
International Journal of Hematology|January 17, 2024
Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapseMasahiro Akimoto, Takuya Miyazaki, Hiroyuki Takahashi, et al.
Pageof 11